Cancel

Selecting Optimal Antiangiogenic Strategies for Patients With Hepatocellular Carcinoma

STATEMENT OF NEED Hepatocellular carcinoma is the sixth most common tumor globally, with an increasing incidence in the United States and Europe. The malignancy is the third leading cause of cancer-related death worldwide and the leading cause of death in patients with cirrhosis. Approximately 40,710 new cases are diagnosed in the United States annually and 28,920 people die of the disease. Patients with HCC continue to have a dismal prognosis, with a 5-year survival rate of 18%. This is du...
Postgraduate Institute for Medicine and i3 Health

Taking Action Against Chronic Hepatitis B Virus Infection: Counseling Patients on Serological Results

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Taking Action Against Chronic Hepatitis B Virus Infection: Determining Which Patients to Treat or Monitor

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States. Only 33% of the estimated one million Americans living with HBV are aware that they are infected, placing them at risk for spreading the infection to others, and developing liver failure, cirrhosis, or hepatocellular carcinoma (HCC). As a result, HBV infection is the most common reason for liver transplantation. Primary care providers are not adequately screening at-risk patients for HBV in...
CME Outfitters, LLC

Problem Based Learning in HBV: A Patient Simulation for Improving Treatment Decisions and Long-Term Care

Hepatitis B virus (HBV) infection is a largely undetected and untreated disease in the United States despite the availability of screening guidelines and prophylactic vaccines. Chronic HBV infection causes severe complications, including cirrhosis and hepatocellular carcinoma in 20% - 30% of patients. As a result, HBV infection is the most common reason for liver transplantation. While recommendations exist, primary care providers are not adequately screening at-risk patients for HBV infect...
CME Outfitters, LLC

Update in Advanced Imaging 2018

Pitfalls in imaging of brain tumors Review of imaging of mediastinal mass MRI of hepatocellular carcinoma Review of imagining of spinal neoplasms MRI of wrist and hand MRI of the hip and much more
UC Davis Health

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients diagnosed with HCC is challenging, as tumor stage and potential underlying liver disease must be considered prior to initiation of therapy. If detected early, surgical resection or liver transplantation are curative options; however, most HCC cases are diagnosed at an advanced stage. For patients with advanced disease, systemic therapy with targeted agents has demonstrated prolong...
Slack Inc.

Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (HCC): Strategies for Incorporating Emerging Immunotherapy Treatment Options

Expert faculty, Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. The activity features an online virtual patient platform that affords clinicians an opportunity to absorb relevant clinical and evidence-based information. The purpose of the activity is to inform clinicians on integrating immunotherapy into treatment options of advanced hepatocellular carcinoma pa...
ACHL

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.